News from the Journal editors:
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing–remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
Read more here: http://onlinelibrary.wiley.com/doi/10.1111/ene.13272/abstract;jsessionid=0132A5AF8858E58DF0705A2CE7C795DF.f04t04
